Paeoniflorin inhibits growth of human colorectal carcinoma HT 29 cells in vitro and in vivo

Food and Chemical Toxicology

Volumn 50, Issue 5, 2012, Pages 1560-1567

  Wang, He ^a   Zhou, Hong ^b   Wang, Cheng Xi ^c   Li, Yue Shan ^a   Xie, Hong Yan ^a   Luo, Jian Dong ^a   Zhou, Yi ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; HT29 cells; In vitro and in vivo; P53; Proliferation

Indexed keywords

CASPASE 3; CASPASE 9; CYCLINE; DOCETAXEL; PAEONIFLORIN; PROTEIN 14 3 3; PROTEIN 14 3 3 ZETA; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL STRAIN HT29; COLON CARCINOMA; COLORECTAL CARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DAMAGE; DRUG EFFICACY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NICK END LABELING; NONHUMAN; PLANT ROOT; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BENZOIC ACIDS; BRIDGED COMPOUNDS; CASPASE 3; CASPASE 9; CELL CYCLE; CELL DIVISION; COLORECTAL NEOPLASMS; ELECTROPHORESIS, AGAR GEL; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GLUCOSIDES; HT29 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, NUDE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS; PAEONIACEAE;

EID: 84862798464     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.01.035     Document Type: Article

References (31)

1. Abdel-Hafez A.A., Meselhy M.R., Nakamura N., Hattori M., Watanabe H., Murakami Y., El-Gendy M.A., Mahfouz N.M., Mohamed T.A. Anticonvulsant activity of paeonimetabtained by incubation of paeoniflorin and thiol compounds with Lactobacillus brevis. Biol. Pharm. Bull. 1999, 22:491-497.
2. Agarwal C., Singh R.P., Agarwal R. Grape seed extract induces apoptotic death of human prostate carcinoma DU145 cells via caspases activation accompanied by dissipation of mitochondrial membrane potential and cytochrome c release. Carcinogenesis 2002, 23:1869-1876.
3. Arber N., Levin B. Chemoprevention of colorectal cancer: ready for routine use?. Recent Results Cancer Res. 2005, 166:213-230.
4. Barton B.E., Karras J.G., Murphy T.F., Barton A., Huang H.F. Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: direct STAT3 inhibition induces apoptosis in prostate cancer lines. Mol. Cancer Ther. 2004, 3:11-20.
5. Cheng J.T., Wang C.J., Hsu F.L. Paeoniflorin reverses guanethidine-induced hypotension via activation of central adenosine A1 receptors in Wistar rats. Clin. Exp. Pharmacol. Physiol. 1999, 26:815-816.
6. Cory S., Adams J.M. Killing cancer cells by flipping the Bcl-2/Bax switch. Cancer cell 2005, 8:5-6.
7. Danes C.G., Wyszomierski S.L., Lu J., Neal C.L., Yang W., Yu D. 14-3-3 Zeta down-regulates p53 in mammary epithelial cells and confers luminal filling. Cancer Res. 2008, 68:1760-1767.
8. Farnebo M., Bykov V.J., Wiman K.G. The p53 tumor suppressor: a master regulator of diverse cellular processes and therapeutic target in cancer. Biochem. Biophys. Res. Commun. 2010, 396:85-89.
9. Fu H., Subramanian R.R., Masters S.C. 14-3-3 Proteins: structure, function, and regulation. Annu. Rev. Pharmacol. Toxicol. 2000, 40:617-647.
10. Hermeking H., Lengauer C., Polyak K., He T.C., Zhang L., Thiagalingam S., Kinzler K.W., Vogelstein B. 14-3-3 Sigma is a p53-regulated inhibitor of G2/M progression. Mol. Cell 1997, 1:3-11.
11. Hsu F.L., Lai C.W., Cheng J.T. Antihyperglycemic effects of paeoniflorin and 8-debenzoylpaeoniflorin, glucosides from the root of Paeonia lactiflora. Planta Med. 1997, 63:323-325.
12. Hung J.Y., Yang C.J., Tsai Y.M., Huang H.W., Huang M.S. Antiproliferative activity of paeoniflorin is through cell cycle arrest and the Fas/Fas ligand-mediated apoptotic pathway in human non-small cell lung cancer A549 cells. Clin. Exp. Pharmacol. Physiol. 2008, 35:141-147.
13. Igney F.H., Krammer P.H. Death and anti-death: tumour resistance to apoptosis. Nat. Rev. Cancer 2002, 2:277-288.
14. Kasibhatla S., Tseng B. Why target apoptosis in cancer treatment?. Mol. Cancer Ther. 2003, 2:573-580.
15. Kimura M., Kimura I., Nojima H. Depolarizing neuromuscular blocking action induced by electropharmacological coupling in the combined effect of paeoniflorin and glycyrrhizin. Jpn. J. Pharmacol. 1985, 37:395-399.
16. Kuo Y.C., Kuo P.L., Hsu Y.L., Cho C.Y., Lin C.C. Ellipticine induces apoptosis through p53-dependent pathway in human hepatocellular carcinoma HepG2 cells. Life Sci. 2006, 78:2550-2557.
17. Kwon, K.B., Kim, E.K., Han, M.J., Shin, B.C., Park, Y.K., Kim, K.S., Lee, Y.R., Park, J.W., Park, B.H., Ryu do, G., 2006. Induction of apoptosis by Radix Paeoniae Alba extract through cytochrome c release and the activations of caspase-9 and caspase-3 in HL-60 cells. Biol. Pharm. Bull. 29, 1082-1086.
18. Lieberman D.A., Prindiville S., Weiss D.G., Willett W. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA 2003, 290:2959-2967.
19. Liu D.F., Wei W., Song L.H. Protective effect of paeoniflorin on immunological liver injury induced by bacillus Calmette-Guerin plus lipopolysaccharide: modulation of tumour necrosis factor-alpha and interleukin-6 MRNA. Clin. Exp. Pharmacol. Physiol. 2006, 33:332-339.
20. Lowe S.W., Ruley H.E., Jacks T., Housman D.E. P53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993, 74:957-967.
21. Ou T.T., Wu C.H., Hsu J.D., Chyau C.C., Lee H.J., Wang C.J. Paeonia lactiflora Pall inhibits bladder cancer growth involving phosphorylation of Chk2 in vitro and in vivo. J. Ethnopharmacol. 2011, 135:162-172.
22. Porter G.W., Khuri F.R., Fu H. Dynamic 14-3-3/client protein interactions integrate survival and apoptotic pathways. Semin. Cancer Biol. 2006, 16:193-202.
23. Radhakrishnan V.M., Putnam C.W., Qi W., Martinez J.D. P53 suppresses expression of the 14-3-3gamma oncogene. BMC Cancer 2011, 11:378.
24. Saito S., Nakano K., Nabeyama A., Sato M., Okafuji N., Yamamoto A., Kasahara E., Kawakami T. Immunohistochemical expression of heat shock protein27 in the mouse dental pulp after immediate teeth separation. Eur. J. Med. Res. 2011, 16:495-500.
25. Samowitz, W.S., Slattery, M.L., 2002. Missense mismatch repair gene alterations, microsatellite instability, and hereditary nonpolyposis colorectal cancer. J. Clin. Oncol. 20, 3178; author reply 3178-3179.
26. Shen Y.X., Min L.H., Qin P.Y., Ping M.I.A. Efects of paeoniflorin on apoptosis and correlative apoptosis regulator gene of human cell strain HepG-2. Chin. Arch. Trad. Chin. Med. 2007, 25:1346-1348.
27. Thorson J.A., Yu L.W., Hsu A.L., Shih N.Y., Graves P.R., Tanner J.W., Allen P.M., Piwnica-Worms H., Shaw A.S. 14-3-3 Proteins are required for maintenance of Raf-1 phosphorylation and kinase activity. Mol. Cell Biol. 1998, 18:5229-5238.
28. Wang Q.W., Lu H.L., Song C.C., Liu H., Xu C.G. Radiosensitivity of human colon cancer cell enhanced by immunoliposomal docetaxel. World J. Gastroenterol. 2005, 11:4003-4007.
29. Wu H., Wei W., Song L., Zhang L., Chen Y., Hu X. Paeoniflorin induced immune tolerance of mesenteric lymph node lymphocytes via enhancing beta 2-adrenergic receptor desensitization in rats with adjuvant arthritis. Int. Immunopharmacol. 2007, 7:662-673.
30. Xu Z., Choudhary S., Voznesensky O., Mehrotra M., Woodard M., Hansen M., Herschman H., Pilbeam C. Overexpression of COX-2 in human osteosarcoma cells decreases proliferation and increases apoptosis. Cancer Res. 2006, 66:6657-6664.
31. Zhou Y., Wang H., Li Y.S., Tao Y.W., Zhang J.Y., Zhang Z.Q. Paeoniflorin increases beta-defensin expression and attenuates lesion in the colonic mucosa from mice with oxazolone-induced colitis. Yao Xue Xue Bao 2010, 45:37-42.